Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

PD-154309 revealed at 211th ACS

April 19, 1996

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Estrasine presented at NCI-EORTC

April 19, 1996

CB-30865 selected for further study

April 19, 1996

Onconase development update

April 19, 1996

Immune Response in-licenses gene therapy for brain tumors

April 12, 1996

NT-3 lessens cisplatin toxicity in rats

April 12, 1996

Thalidomide in phase II at NCI for cancer indications

April 12, 1996

Banyu reports synthesis and activity of BE-39907A2

April 12, 1996

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...